Lv1
98 积分 2025-07-20 加入
Electrochemically induced amorphous-to-rock-salt phase transformation in niobium oxide electrode for Li-ion batteries
9天前
已完结
Pulsed electrolysis for stable electrocatalysis
14天前
已完结
Microenvironment effects in electrochemical CO2 reduction from first-principles multiscale modelling
2个月前
已完结
Catalyst electro-redeposition controls morphology and oxidation state for selective carbon dioxide reduction
4个月前
已完结
Strengthening Ni alloys with nanoscale interfaces of negative excess energy
6个月前
已完结
Giant photoconductance at infinite-layer nickelate/SrTiO3 interfaces via an optically induced high-mobility electron gas
7个月前
已完结
Seed-assisted formation of NiFe anode catalysts for anion exchange membrane water electrolysis at industrial-scale current density
7个月前
已完结
Electrifying industrial hydrogen peroxide production via soft interfacial molecular mediation
7个月前
已完结
Self‐Supporting Ni‐M (M = Mo, Ge, Sn) Alloy Nanosheets via Topotactic Transformation of Oxometallate Intercalated Layered Nickel Hydroxide Salts: Synthesis and Application for Electrocatalytic Hydrogen Evolution Reaction
7个月前
已完结
Diffusion processes in the FeNi system
9个月前
已完结
Assembly of thiazole-2-thiones through cyclization of enaminones, aryl isothiocyanates, and elemental sulfur
9个月前
已采纳
Preparation and characterization of the ground mixture of rebamipide commercial tablets and Hydroxypropyl Cellulose-SSL by ball-milling: Application to the dispersoid of mouthwash suspension
9个月前
已采纳
Regulating the Characteristic Networks of Biodegradable Poly(l-malic acid-ε-caprolactone) Shape-Memory Materials: From Plastics to Elastomers
9个月前
已采纳
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
9个月前
已采纳
NH3-SCR over Fe/SSZ-13 catalyst prepared by modification of natural chabazite
9个月前
已采纳
Hydrophobic, Acid-Free Zeolite-Confined Pt–Cu Nanoalloys Break Activity–Selectivity Limits in Low-Temperature Methane-to-Methanol Oxidation
9个月前
已采纳
Daratumumab for High-Risk Smoldering Multiple Myeloma
9个月前
已采纳
皖公网安备34019202002308
